Intra-Cellular Therapies Inc (ITCI) stock saw a modest uptick, ending the day at $126.5 which represents a slight increase of $0.30 or 0.24% from the prior close of $126.2. The stock opened at $126.64 ...

In a report released today, Scott Siefers from Piper Sandler maintained a Buy rating on Fifth Third Bancorp (FITB – Research Report), with a ...

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Moderna (MRNA – Research Report), with a price target ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 73.46% ...

Fintel reports that on January 6, 2025, Goldman Sachs downgraded their outlook for Piper Sandler Companies (NYSE:PIPR) from Buy to Neutral. Analyst Price Forecast Suggests 25.14% Upside As of December ...

Charles Schwab (NYSE:SCHW – Get Free Report) had its price objective upped by research analysts at Morgan Stanley from $74.00 ...

Morgan Stanley upgraded shares of Clearwater Analytics (NYSE:CWAN – Free Report) from an equal weight rating to an overweight rating in a report published on Friday, Marketbeat Ratings reports. Morgan ...